Literature DB >> 12678138

Compliance with treatment of adult epileptics in a rural district of Thailand.

Thanin Asawavichienjinda1, Chitr Sitthi-Amorn, Wacharin Tanyanont.   

Abstract

BACKGROUND: Epilepsy, a disease when seizures can occur from antiepileptic drug withdrawal, requires regular drug taking. Non-compliance, therefore, is a major factor contributing to sub-optimal control of the seizures.
PURPOSE: To determine the factors associated with noncompliance in epileptics in rural Thailand.
METHOD: All epileptics, registered in the Pak Thong Chai District and their caregivers were invited to be interviewed and examined by a neurologist in their village.
RESULTS: Of a total of 93 epileptics registered, 83 with their caregivers were interviewed and examined by the neurologist (T.A.) and of those 72 were adults. Of the 72 adult epileptics, 41 (56.9%) were 100 per cent compliant and factors found to be significantly associated with compliance were gender, household income and patient's health insurance (p-value < 0.05). The major reasons for non-compliance were misunderstanding (48.4%), forgetfulness (16.1%) and economic problem (12.9%).
CONCLUSION: To improve patient-compliance, the real factors for non-compliance, which are unique to patients in a specific area, need to be identified.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12678138

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  9 in total

1.  Adherence to medication among outpatient adolescents with epilepsy.

Authors:  Wael M Gabr; Mohamed E E Shams
Journal:  Saudi Pharm J       Date:  2014-05-26       Impact factor: 4.330

Review 2.  The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies.

Authors:  Caroline K Mbuba; Anthony K Ngugi; Charles R Newton; Julie A Carter
Journal:  Epilepsia       Date:  2008-06-13       Impact factor: 5.864

3.  Epilepsy: Indian perspective.

Authors:  Nandanavana Subbareddy Santhosh; Sanjib Sinha; Parthasarathy Satishchandra
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

4.  Evaluation of self-reported medication adherence and its associated factors among epilepsy patients in Hospital Kuala Lumpur.

Authors:  Nagashekhara Molugulu; Kumar Shiva Gubbiyappa; C R Vasudeva Murthy; Lim Lumae; Anil Tumkur Mruthyunjaya
Journal:  J Basic Clin Pharm       Date:  2016-09

5.  Which Matters More for Medication Adherence Among Disabled People in Shanghai, China: Family Support or Primary Health Care?

Authors:  Jiaoling Huang; Zhiyun Jiang; Tao Zhang; Luan Wang; Yiming Chu; Mei Shen; Hong Liang; Shanshan Liu; Yimin Zhang; Chengjun Liu
Journal:  Inquiry       Date:  2019 Jan-Dec       Impact factor: 1.730

6.  Impact of the implementation of the AAN epilepsy quality measures on the medical records in a university hospital.

Authors:  J Miguel Cisneros-Franco; Marco A Díaz-Torres; Juan B Rodríguez-Castañeda; Alejandro Martínez-Silva; Mildred A Gutierrez-Herrera; Daniel San-Juan
Journal:  BMC Neurol       Date:  2013-08-28       Impact factor: 2.474

7.  Medicine possession ratio as proxy for adherence to antiepileptic drugs: prevalence, associations, and cost implications.

Authors:  Karen Jacobs; Marlene Julyan; Martie S Lubbe; Johanita R Burger; Marike Cockeran
Journal:  Patient Prefer Adherence       Date:  2016-04-12       Impact factor: 2.711

8.  Adherence and treatment satisfaction in liver transplant recipients.

Authors:  Abdulkareem M Albekairy; Abdulmalik M Alkatheri; Anan Jarab; Nabil Khalidi; Khalifah Althiab; Abdulrahman Alshaya; Khalid Bin Saleh; Wesam W Ismail; Amjad M Qandil
Journal:  Saudi J Gastroenterol       Date:  2016 Mar-Apr       Impact factor: 2.485

Review 9.  The impact of social, national and community-based health insurance on health care utilization for mental, neurological and substance-use disorders in low- and middle-income countries: a systematic review.

Authors:  Sumaiyah Docrat; Donela Besada; Susan Cleary; Crick Lund
Journal:  Health Econ Rev       Date:  2020-04-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.